Details of the Drug

General Information of Drug (ID: DM3K95H)

Drug Name

APZ-2

Indication

Disease Entry	ICD 11	Status	REF
Epidermolysis bullosa	EC3Z	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05838092) A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Trial to Investigate the Safety and Efficacy of ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) on Epidermolysis Bullosa (EB). U.S.National Institutes of Health.